Professor Lukas Kairaitis

Professor Lukas Kairaitis

Clinical Sub Dean,
School of Medicine



  • PhD University of Sydney
  • MBBS University of Sydney

Organisational Unit (School / Division)

  • School of Medicine


Phone: (02) 9851 6055
Location: Off Campus

PLEASE NOTE: obtaining information from this Directory must be for the legitimate purposes of doing business with and within Western Sydney University, and must not be used for unsolicited bulk e-mailing (spamming) or similar purposes.



  • Harris, D., Elder, G., Kairaitis, L. and Ragan, G. (2005), 'Basic Clinical Dialysis 1st Edition', : McGraw-Hill 9780074715017.

Journal Articles

  • Hansen, M., Tesfaye, W., Sewlal, B., Mehta, B., Sud, K., Kairaitis, L., Tarafdar, S., Chau, K., Zaidi, S. and Castelino, R. (2022), 'Psychosocial factors affecting patients with end-stage kidney disease and the impact of the social worker', Journal of Nephrology, vol 35, no 1 , pp 43 - 58.
  • Swinnen, J., Hitos, K., Kairaitis, L., Gruenewald, S., Larcos, G., Farlow, D., Huber, D., Cassorla, G., Leo, C., Villalba, L., Allen, R., Niknam, F. and Burgess, D. (2019), 'Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses', The Journal of Vascular Access, vol 20, no 3 , pp 260 - 269.
  • Castelino, R., Maddula, M., Tarafdar, S., Sud, K. and Kairaitis, L. (2019), 'Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia : need for a higher than recommended weight-based dosing', Thrombosis Research, vol 180 , pp 70 - 73.
  • Kairaitis, L., Collett, J. and Swinnen, J. (2018), 'Diameter of inflow as a predictor of radiocephalic fistula flow', Journal of Vascular Access, vol 19, no 6 , pp 548 - 554.
  • Hanson, C., Chapman, J., Craig, J., Harris, D., Kairaitis, L., Nicdao, M., Mikaheal, M. and Tong, A. (2017), 'Patient experiences of training and transition to home haemodialysis : a mixed-methods study', Nephrology, vol 22, no 8 , pp 631 - 641.
  • Chapman, F., Nicdao, M. and Kairaitis, L. (2016), 'The hidden burden of high-flow fistulae in a home haemodialysis programme : outcomes of initiating arteriovenous fistula monitoring in the home haemodialysis population', Renal Society of Australasia Journal, vol 12, no 1 , pp 6 - 11.
  • Fortnum, D., Smolonogov, T., Walker, R., Kairaitis, L. and Pugh, D. (2015), ''My Kidneys, My Choice, decision aid' : supporting shared decision making', Journal of Renal Care, vol 41, no 2 , pp 81 - 87.
  • Fahrtash, F., Kairaitis, L., Guenewald, S., Spicer, T., Sidrak, H., Fletcher, J., Allen, R. and Swinnen, J. (2011), 'Defining a significant stenosis in an autologous radio-cephalic arteriovenous fistula for hemodialysis', Seminars in Dialysis, vol 24, no 2 , pp 231 - 238.
  • Yong, K. and Kairaitis, L. (2010), 'Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort', Nephrology, vol 15, no 3 , pp 288 - 293.
  • Blyth, E., Favaloro, E., Harris, D. and Kairaitis, L. (2008), 'Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis', Blood Coagulation and Fibrinolysis, vol 19, no 1 , pp 23 - 25.
  • Kairaitis, L. (2007), 'Prevention of recurrent calcium nephrolithiasis. (Carlton)', Nephrology, vol 1 , pp 11 - 20.
  • Zheng, G., Zheng, L., Wu, H., Kairaitis, L., Zhang, C., Tay, Y., Wang, Y., Alexander, S. and Harris, D. (2006), 'NK cells do not mediate renal injury in murine adriamycin nephropathy', Kidney International, vol 69, no 7 , pp 1156 - 1165.
  • Kairaitis, L., Wang, Y., Gassmann, M., Tay, Y. and Harris, D. (2005), 'HIF-10 expression follows microvascular loss in advanced murine Adriamycin nephrosis', American Journal Physiology, vol 288, no 1 , pp 198 - 206.
  • Geevasinga, N., Kairaitis, L., Rangan, G. and Coleman, P. (2005), 'Acute interstitial nephritis secondary to esomeprazole', Medical Journal of Australia, vol 182, no 5 , pp 235 - 236.
  • Tay, Y., Wang, Y., Kairaitis, L., Rangan, G., Zhang, C. and Harris, D. (2005), 'Can murine diabetic nephropathy be separated from superimposed acute renal failure?', Kidney International, vol 68, no 1 , pp 391 - 398.
  • Wang, Y., Mahajan, D., Tay, Y., Bao, S., Spicer, T., Kairaitis, L., Rangan, G. and Harris, D. (2005), 'Partial depletion of macrophages by ED7 reduces renal injury in adriamycin nephropathy', Nephrology, vol 10, no 5 , pp 470 - 477.
  • Sadlier, D., Connolly, S., Kieran, N., Roxburgh, S., Bazil, D., Kairaitis, L., Wang, Y., Harris, D., Doran, P. and Brady, H. (2004), 'Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy', Journal of Biological Chemistry, vol 279, no 28 , pp 29670 - 29680.
  • Kairaitis, L., Wang, Y., Zheng, L., Tay, Y., Wang, Y. and Harris, D. (2003), 'Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease', Kidney International, vol 64, no 4 , pp 1265 - 1272.
  • Wang, Y., Shounan, Y., Yuet-Shing, T., Feng, X., Wang, Y., Kairaitis, L. and Harris, D. (2002), 'Transfection of tubule cells with Fas ligand causes leukocyte apoptosis', Kidney International, vol 61, no 4 , pp 1303 - 1311.
  • Chen, L., Wang, Y., Kairaitis, L., Wang, Y., Zhang, B. and Harris, D. (2001), 'Molecular mechanisms by which iron induces nitric oxide synthesis in cultured proximal tubule cells', Experimental Nephrology, vol 9, no 3 , pp 198 - 204.
  • Wang, Y., Wang, Y., Feng, X., Bao, S., Kairaitis, L., Tay, Y., Rangan, G. and Harris, D. (2001), 'Depletion of CD4<sup>+</sup> T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy', Kidney International, vol 59, no 3 , pp 975 - 984.
  • Kairaitis, L. and Harris, D. (2001), 'Tubular-interstitial interactions in proteinuric renal diseases', Nephrology, vol 6, no 5 , pp 198 - 207.

Western Sydney University

Locked Bag 1797
Penrith NSW 2751

Tel: +61 2 9852 5222

ABN 53 014 069 881
CRICOS Provider No: 00917k